Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Erben

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
International Journal of Oncology|February 16, 2017
RAB27A, RAB27B and VPS36 are downregulated in advanced prostate cancer and show functional relevance in prostate cancer cellsThomas Stefan Worst, Yannic Meyer, Maria Gottschalt, et al.
Plos One|November 13, 2012
HERV-E-mediated modulation of PLA2G4A transcription in urothelial carcinomaDarko Gosenca, Ute Gabriel, Annette Steidler, et al.
International Journal of Molecular Sciences|April 30, 2021
RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based ChemotherapyJonas Herrmann, Helena Schmidt, Katja Nitschke, et al.
Onkologie|September 15, 2010
Annexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy?Karoline Horisberger, Philipp Erben, Philipp Ströbel, et al.
Genes|April 30, 2021
Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder CancerSarah Förster, Maryam Givehchi, Katja Nitschke, et al.
Anti-Cancer Drugs|May 14, 2009
Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancerKaroline Horisberger, Philipp Erben, Benjamin Muessle, et al.
Oncotarget|May 13, 2017
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypesSebastien Rinaldetti, Ralph Markus Wirtz, Thomas Stefan Worst, et al.
Virchows Archiv : an International Journal of Pathology|January 12, 2017
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survivalJohannes Breyer, Ralph M Wirtz, Wolfgang Otto, et al.
Gastroenterology Research and Practice|September 10, 2016
Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal CancerMelanie Kripp, Kirsten Merx, Ralph Markus Wirtz, et al.
International Journal of Molecular Sciences|June 25, 2020
Phosphodiesterase <i>SMPDL3B</i> Gene Expression as Independent Outcome Prediction Marker in Localized Prostate CancerFrank Waldbillig, Katja Nitschke, Abdallah Abdelhadi, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Oncology|February 16, 2017
RAB27A, RAB27B and VPS36 are downregulated in advanced prostate cancer and show functional relevance in prostate cancer cellsThomas Stefan Worst, Yannic Meyer, Maria Gottschalt, et al.
Plos One|November 13, 2012
HERV-E-mediated modulation of PLA2G4A transcription in urothelial carcinomaDarko Gosenca, Ute Gabriel, Annette Steidler, et al.
International Journal of Molecular Sciences|April 30, 2021
RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based ChemotherapyJonas Herrmann, Helena Schmidt, Katja Nitschke, et al.
Onkologie|September 15, 2010
Annexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy?Karoline Horisberger, Philipp Erben, Philipp Ströbel, et al.
Genes|April 30, 2021
Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder CancerSarah Förster, Maryam Givehchi, Katja Nitschke, et al.
Anti-Cancer Drugs|May 14, 2009
Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancerKaroline Horisberger, Philipp Erben, Benjamin Muessle, et al.
Oncotarget|May 13, 2017
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypesSebastien Rinaldetti, Ralph Markus Wirtz, Thomas Stefan Worst, et al.
Virchows Archiv : an International Journal of Pathology|January 12, 2017
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survivalJohannes Breyer, Ralph M Wirtz, Wolfgang Otto, et al.
Gastroenterology Research and Practice|September 10, 2016
Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal CancerMelanie Kripp, Kirsten Merx, Ralph Markus Wirtz, et al.
International Journal of Molecular Sciences|June 25, 2020
Phosphodiesterase <i>SMPDL3B</i> Gene Expression as Independent Outcome Prediction Marker in Localized Prostate CancerFrank Waldbillig, Katja Nitschke, Abdallah Abdelhadi, et al.
Pageof 13